Agenus :: the patient is waiting
The patient is waiting
About Us
QS-21
HerpV
Prophage Series
Partners
Investors
Media
Contact Us
Press Release (4/17/12):
New Phase 2 Data from Brain Cancer Study with Agenus’ Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS